Zhende Medical Co Ltd (603301) - Total Assets
Based on the latest financial reports, Zhende Medical Co Ltd (603301) holds total assets worth CN¥8.36 Billion CNY (≈ $1.22 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 603301 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Zhende Medical Co Ltd - Total Assets Trend (2014–2025)
This chart illustrates how Zhende Medical Co Ltd's total assets have evolved over time, based on quarterly financial data. Check Zhende Medical Co Ltd (603301) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Zhende Medical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Zhende Medical Co Ltd's total assets of CN¥8.36 Billion consist of 34.0% current assets and 66.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 9.8% |
| Accounts Receivable | CN¥703.05 Million | 8.4% |
| Inventory | CN¥754.13 Million | 9.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥737.31 Million | 8.8% |
| Goodwill | CN¥1.04 Billion | 12.3% |
Asset Composition Trend (2014–2025)
This chart illustrates how Zhende Medical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Zhende Medical Co Ltd (603301) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhende Medical Co Ltd's current assets represent 34.0% of total assets in 2025, a decrease from 52.0% in 2014.
- Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, up from 8.4% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 20.0% of total assets, an increase from 7.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 12.3% of total assets.
Zhende Medical Co Ltd Competitors by Total Assets
Key competitors of Zhende Medical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tecan Group AG
SW:TECN
|
Switzerland | CHF1.94 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
|
China | CN¥2.06 Billion |
|
Formosa Optical Technology Co Ltd
TWO:5312
|
Taiwan | NT$9.15 Billion |
|
ZEN Graphene Solutions Ltd
V:ZEN
|
Canada | CA$16.87 Million |
|
GETS Global Bhd
KLSE:5079
|
Malaysia | RM400.10 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
Zhende Medical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.64 | 2.00 | 2.12 |
| Quick Ratio | 1.16 | 1.47 | 1.66 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.11 Billion | CN¥1.53 Billion | CN¥2.12 Billion |
Zhende Medical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhende Medical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.37 |
| Latest Market Cap to Assets Ratio | 0.41 |
| Asset Growth Rate (YoY) | 10.9% |
| Total Assets | CN¥8.40 Billion |
| Market Capitalization | $3.44 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhende Medical Co Ltd's assets below their book value (0.41x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Zhende Medical Co Ltd's assets grew by 10.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Zhende Medical Co Ltd (2014–2025)
The table below shows the annual total assets of Zhende Medical Co Ltd from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥8.40 Billion ≈ $1.23 Billion |
+10.88% |
| 2024-12-31 | CN¥7.58 Billion ≈ $1.11 Billion |
+4.27% |
| 2023-12-31 | CN¥7.27 Billion ≈ $1.06 Billion |
-7.98% |
| 2022-12-31 | CN¥7.90 Billion ≈ $1.16 Billion |
+22.97% |
| 2021-12-31 | CN¥6.42 Billion ≈ $939.69 Million |
+0.34% |
| 2020-12-31 | CN¥6.40 Billion ≈ $936.53 Million |
+139.77% |
| 2019-12-31 | CN¥2.67 Billion ≈ $390.59 Million |
+44.29% |
| 2018-12-31 | CN¥1.85 Billion ≈ $270.71 Million |
+42.98% |
| 2017-12-31 | CN¥1.29 Billion ≈ $189.34 Million |
+14.71% |
| 2016-12-31 | CN¥1.13 Billion ≈ $165.05 Million |
-11.53% |
| 2015-12-31 | CN¥1.27 Billion ≈ $186.56 Million |
+14.88% |
| 2014-12-31 | CN¥1.11 Billion ≈ $162.39 Million |
-- |
About Zhende Medical Co Ltd
Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pa… Read more